<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.8.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//www.biotechreality.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://www.biotechreality.com/2026/09/astrazeneca-etcamah-serena-4-trial-misses.html</loc>
  <lastmod>2026-09-12T07:19:48Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AstraZeneca Etcamah SERENA-4 Trial Misses Primary Endpoint in First-Line Breast Cancer Study</news:title>
   <news:publication_date>2026-09-12T07:18:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/09/kyowa-kirin-khk4951-namd-phase-2-results.html</loc>
  <lastmod>2026-09-12T07:19:32Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Kyowa Kirin KHK4951 Eye Drops Report Phase 2 nAMD Data as Primary Endpoint Is Missed</news:title>
   <news:publication_date>2026-09-11T18:03:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/09/roche-enspryng-mogad-fda-priority-review.html</loc>
  <lastmod>2026-09-10T18:32:33Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Roche Enspryng MOGAD Filing Wins FDA Priority Review as First Potential Treatment for Rare Neuroimmune Disease</news:title>
   <news:publication_date>2026-09-10T18:20:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/09/charles-river-endosafe-cartridge-automated-manufacturing.html</loc>
  <lastmod>2026-09-09T20:01:03Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Charles River Endosafe Cartridge Manufacturing Goes Fully Automated at Massachusetts Facility</news:title>
   <news:publication_date>2026-09-09T20:00:57Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
